1. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium
- Author
-
Peter J. Frederick, Alice H. Hsu, Gustavo Leone, Takiko Daikoku, Subodh M. Lele, Sudhansu K. Dey, Kang Sup Shim, Adrian R. Black, Michelle A. Lum, Baojiang Chen, Carl Morrison, Jennifer D. Black, and Yuri Sheinin
- Subjects
0301 basic medicine ,Protein Kinase C-alpha ,Carcinogenesis ,Phosphatase ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Article ,law.invention ,03 medical and health sciences ,Endometrium ,Mice ,Phosphatidylinositol 3-Kinases ,law ,Cell Line, Tumor ,medicine ,Phosphoprotein Phosphatases ,PTEN ,Animals ,Humans ,Protein Phosphatase 2 ,Phosphorylation ,lcsh:QH301-705.5 ,Protein kinase B ,Protein kinase C ,PI3K/AKT/mTOR pathway ,biology ,Chemistry ,Endometrial cancer ,PTEN Phosphohydrolase ,Nuclear Proteins ,medicine.disease ,3. Good health ,Endometrial Neoplasms ,Enzyme Activation ,Disease Models, Animal ,030104 developmental biology ,HEK293 Cells ,lcsh:Biology (General) ,Cancer research ,biology.protein ,Suppressor ,Female ,Neoplasm Grading ,Proto-Oncogene Proteins c-akt ,Signal Transduction - Abstract
SUMMARY Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their activation by tumor-promoting phorbol esters. However, accumulating evidence indicates that PKCs can be inhibitory in some cancers, with recent findings propelling a shift in focus to understanding tumor suppressive functions of these enzymes. Here, we report that PKCα acts as a tumor suppressor in PI3K/AKT-driven endometrial cancer. Transcriptional suppression of PKCα is observed in human endometrial tumors in association with aggressive disease and poor prognosis. In murine models, loss of PKCα is rate limiting for endometrial tumor initiation. PKCα tumor suppression involves PP2A-family-dependent inactivation of AKT, which can occur even in the context of genetic hyperactivation of PI3K/AKT signaling by coincident mutations in PTEN, PIK3CA, and/or PIK3R1. Together, our data point to PKCα as a crucial tumor suppressor in the endometrium, with deregulation of a PKCα→PP2A/PP2A-like phosphatase signaling axis contributing to robust AKT activation and enhanced endometrial tumorigenesis., Graphical Abstract, In Brief Hsu et al. find that PKCα is frequently lost in human and murine endometrial tumors and that PKCα deficiency enhances PI3K/ AKT-driven endometrial neoplasia. PKCα suppresses aberrant AKT activity via a PP2A family phosphatase-dependent mechanism. Thus, PKCα loss appears to cooperate with PI3K/AKT perturbations to hyperactivate AKT and promote endometrial tumorigenesis.
- Published
- 2018